500,000 Shares in CVS Health Co. (NYSE:CVS) Acquired by Integral Health Asset Management LLC

Integral Health Asset Management LLC bought a new position in shares of CVS Health Co. (NYSE:CVS) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 500,000 shares of the pharmacy operator’s stock, valued at approximately $22,445,000. CVS Health accounts for approximately 1.9% of Integral Health Asset Management LLC’s holdings, making the stock its 13th biggest position.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Wealth Enhancement Advisory Services LLC boosted its position in shares of CVS Health by 1.3% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 173,643 shares of the pharmacy operator’s stock worth $7,795,000 after purchasing an additional 2,256 shares during the last quarter. Graypoint LLC boosted its position in shares of CVS Health by 15.2% in the 4th quarter. Graypoint LLC now owns 5,187 shares of the pharmacy operator’s stock worth $233,000 after purchasing an additional 683 shares during the last quarter. Czech National Bank boosted its position in shares of CVS Health by 6.4% in the 4th quarter. Czech National Bank now owns 272,854 shares of the pharmacy operator’s stock worth $12,248,000 after purchasing an additional 16,424 shares during the last quarter. Brookstone Capital Management boosted its position in shares of CVS Health by 10.9% in the 4th quarter. Brookstone Capital Management now owns 69,420 shares of the pharmacy operator’s stock worth $3,116,000 after purchasing an additional 6,831 shares during the last quarter. Finally, Moody National Bank Trust Division lifted its holdings in CVS Health by 3.8% during the fourth quarter. Moody National Bank Trust Division now owns 24,185 shares of the pharmacy operator’s stock worth $1,086,000 after acquiring an additional 885 shares in the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at CVS Health

In other news, Director Michael F. Mahoney acquired 30,000 shares of the business’s stock in a transaction on Tuesday, February 18th. The shares were acquired at an average cost of $66.70 per share, with a total value of $2,001,000.00. Following the transaction, the director now owns 39,356 shares in the company, valued at $2,625,045.20. The trade was a 320.65% increase in their position. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. Also, SVP James David Clark sold 7,513 shares of CVS Health stock in a transaction that occurred on Wednesday, March 5th. The shares were sold at an average price of $66.35, for a total transaction of $498,487.55. Following the transaction, the senior vice president now owns 8,394 shares of the company’s stock, valued at $556,941.90. The trade was a 47.23% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.22% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

CVS has been the subject of a number of research analyst reports. Argus set a $77.00 target price on CVS Health in a research note on Tuesday, February 18th. StockNews.com raised CVS Health from a “hold” rating to a “buy” rating in a research note on Friday. Cantor Fitzgerald upgraded CVS Health from a “neutral” rating to an “overweight” rating in a report on Wednesday, February 12th. Truist Financial boosted their price target on CVS Health from $76.00 to $82.00 and gave the company a “buy” rating in a report on Friday, April 11th. Finally, Cowen restated a “buy” rating on shares of CVS Health in a report on Monday, May 5th. Three research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $74.81.

CVS Health Stock Down 1.3%

CVS opened at $66.98 on Monday. The stock has a market cap of $84.73 billion, a PE ratio of 18.30, a P/E/G ratio of 0.98 and a beta of 0.60. The company has a quick ratio of 0.60, a current ratio of 0.81 and a debt-to-equity ratio of 0.80. CVS Health Co. has a 52 week low of $43.56 and a 52 week high of $72.51. The business’s fifty day simple moving average is $66.96 and its 200 day simple moving average is $59.06.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.62 by $0.63. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. The firm had revenue of $94.59 billion for the quarter, compared to analysts’ expectations of $93.07 billion. During the same period last year, the firm earned $1.31 earnings per share. The company’s revenue for the quarter was up 7.0% compared to the same quarter last year. As a group, research analysts expect that CVS Health Co. will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, May 1st. Stockholders of record on Tuesday, April 22nd were issued a dividend of $0.665 per share. The ex-dividend date was Tuesday, April 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.97%. CVS Health’s dividend payout ratio is currently 63.48%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.